TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02460302

Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy

Cause of deathStaffing, sites or logistics, also funding or business Automatic label, confidence 0.6, unverified. How labels are made.
“Inadequate staffing and funds”

The sponsor’s own words in the registry.

Life of this trial

20152016201720182019202020212022202320242025Registered2015-05-29Planned start2016-12 (planned)Withdrawn (as of)2024-03-20

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
Mount Sinai Hospital, Canada
Sponsor type
University, hospital or other
Conditions
Atrophic Vaginitis; Menopause; Vulvovaginal Atrophy
Interventions
Vaginal progesterone; Placebo
Participants
0
Sites
1
Countries
Canada

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.